BerandaAGIO • NASDAQ
add
Agios Pharmaceuticals Inc
$29,69
Sebelum Jam Perdagangan Normal:(0,00%)0,00
$29,69
Tutup: 1 Mei, 00.30.36 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$29,10
Rentang hari
$28,28 - $30,06
Rentang tahun
$23,42 - $62,58
Kapitalisasi pasar
1,72 M USD
Volume Rata-Rata
666,04 rb
Rasio P/E
2,55
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 10,73 jt | 51,06% |
Biaya operasional | 51,70 jt | 46,43% |
Laba bersih | -96,52 jt | -0,61% |
Margin laba bersih | -899,56 | 33,40% |
Penghasilan per saham | -1,74 | -1,16% |
EBITDA | -123,67 jt | -17,92% |
Tarif pajak efektif | 8,42% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 893,71 jt | 15,03% |
Total aset | 1,66 M | 77,48% |
Total liabilitas | 122,24 jt | -3,06% |
Total ekuitas | 1,54 M | — |
Saham yang beredar | 57,30 jt | — |
Harga terhadap nilai buku | 1,08 | — |
Tingkat pengembalian aset | -18,09% | — |
Tingkat pengembalian modal | -19,03% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -96,52 jt | -0,61% |
Kas dari operasi | -133,17 jt | -83,71% |
Kas dari investasi | -49,16 jt | -151,47% |
Kas dari pembiayaan | 4,84 jt | 471,66% |
Perubahan kas bersih | -177,48 jt | -843,48% |
Arus kas bebas | -108,06 jt | -155,48% |
Tentang
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Didirikan
2008
Situs
Karyawan
487
